Therapeutic Areas: Hematology | Immunology | Genetic Disease

Amyloidosis Clinical Trials

A listing of Amyloidosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis

California

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of AL Amyloidosis

Duarte California 91010

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

San Diego California 92103

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

San Francisco California 94158

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

San Francisco California 94143

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

San Francisco California 94143

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Stanford California 94305

A clinical trial seeking patients for a research study for the treatment of AL Amyloidosis

Stanford California 94305

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Stanford California 94305

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Stanford California 94305

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis

Colorado

Aurora Colorado 80045

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Denver Colorado 80218

A clinical trial seeking patients for a research study for the treatment of AL Amyloidosis

Denver Colorado 80218

A clinical trial seeking patients for a research study for the treatment of AL Amyloidosis

Denver Colorado 80218

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis

Connecticut

New Haven Connecticut 06510

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Florida

Deerfield Beach Florida 33442

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Jacksonville Florida 32224

A clinical trial seeking patients for a research study for the treatment of AL Amyloidosis

Jacksonville Florida 32224

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis

Miami Florida 33136

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Miami Florida 33136

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Miami Florida 33312

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis

Georgia

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis

Illinois

Chicago Illinois 60637

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Chicago Illinois 60611

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Chicago Illinois 60637

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Chicago Illinois 60611

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Chicago Illinois 60637

A clinical trial seeking patients for a research study for the treatment of AL Amyloidosis

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Chicago Illinois 60611

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis

Chicago Illinois 60637

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis

Oak Lawn Illinois 60453

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Oak Lawn Illinois 60453

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Indiana

Indianapolis Indiana 46202

A clinical trial seeking patients for a research study for the treatment of AL Amyloidosis

Indianapolis Indiana 46202

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis

Louisiana

New Orleans Louisiana 70121

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

New Orleans Louisiana

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis

Maryland

Baltimore Maryland 21201

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Baltimore Maryland 21287

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Baltimore Maryland 21201

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Baltimore Maryland 21201

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Baltimore Maryland 21205

Patients are needed to participate in a clinical research study of NEOD001 and Placebo to evaluate Primary Systemic Amyloidosis